{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T16:55:11Z","timestamp":1781715311327,"version":"3.54.5"},"reference-count":23,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: The prognostic significance of pelvic lymph node (PLN) count in surgically staged endometrial cancer remains controversial. This study aimed to evaluate the impact of PLN count on overall survival (OS), disease-free survival (DFS), and recurrence patterns in a large cohort of patients with endometrial cancer. Materials and Methods: This retrospective cohort study included 560 patients with endometrial cancer who underwent total hysterectomy, bilateral salpingo-oophorectomy, and pelvic and\/or para-aortic lymph node assessment between January 2005 and May 2025 at a tertiary referral center. Patients were stratified according to the number of harvested pelvic lymph nodes (\u226420 vs. &gt;20). Clinicopathological characteristics, adjuvant treatments, recurrence patterns, and survival outcomes were analyzed. Survival analyses were performed using Kaplan\u2013Meier estimates and Cox proportional hazards regression models. Results: Of the 560 patients, 262 (46.8%) had \u226420 pelvic lymph nodes harvested and 298 (53.2%) had &gt;20. The median follow-up duration was 64.5 months. Patients with &gt;20 pelvic lymph nodes had larger tumors, higher FIGO stage, and more frequent para-aortic lymphadenectomy. In multivariate analysis, age, non-endometrioid histology, advanced FIGO stage, tumor grade, and lymphatic metastasis were independently associated with both OS and DFS. Pelvic lymph node count was not independently associated with OS or DFS. Overall recurrence rates were similar between groups; however, recurrence patterns differed significantly, with distant recurrences more frequent in the \u226420 PLN group and local recurrences more common in the &gt;20 PLN group. Conclusions: In surgically staged endometrial cancer, a higher pelvic lymph node count (&gt;20 nodes) was not independently associated with survival or recurrence outcomes after adjustment for established prognostic factors, although recurrence patterns differed between groups. Survival was primarily determined by age, histologic subtype, FIGO stage, tumor grade, and lymphatic metastasis. Pelvic lymph node count appears to reflect surgical staging intensity and intraoperative risk assessment rather than serving as an independent determinant of prognosis.<\/jats:p>","DOI":"10.3390\/medicina62020399","type":"journal-article","created":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T08:51:09Z","timestamp":1771491069000},"page":"399","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prognostic Impact of Pelvic Lymph Node Count in Surgically Staged Endometrial Cancer"],"prefix":"10.3390","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8826-6481","authenticated-orcid":false,"given":"Yakup","family":"Yalcin","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, School of Medicine, Bursa Uludag University, Bursa 16110, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1460-6524","authenticated-orcid":false,"given":"Kemal","family":"Ozerkan","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, School of Medicine, Bursa Uludag University, Bursa 16110, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,2,19]]},"reference":[{"key":"ref_1","first-page":"17","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ijgo.2009.02.010","article-title":"Revised FIGO staging for carcinoma of the endometrium","volume":"105","author":"Creasman","year":"2009","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Yalcin, Y., Kosan, B., Yalcin, S., Sakinmaz, M., and Ozerkan, K. (2025). The effect of para-aortic lymphadenectomy on survival in early-stage endometrioid grade 3 and non-endometrioid endometrial cancers. BMC Womens Health, 25.","DOI":"10.1186\/s12905-025-04126-y"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e423","DOI":"10.1016\/S1470-2045(25)00167-6","article-title":"ESGO\u2013ESTRO\u2013ESP guidelines for the management of patients with endometrial carcinoma: Update 2025","volume":"26","author":"Concin","year":"2025","journal-title":"Lancet Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/AOG.0000000000000372","article-title":"Lymphedema after surgery for endometrial cancer: Prevalence, risk factors, and quality of life","volume":"124","author":"Yost","year":"2014","journal-title":"Obstet. Gynecol."},{"key":"ref_6","first-page":"CD007585","article-title":"Lymphadenectomy for the management of endometrial cancer","volume":"9","author":"Frost","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S0140-6736(09)62002-X","article-title":"Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): A retrospective cohort analysis","volume":"375","author":"Todo","year":"2010","journal-title":"Lancet"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s11701-025-02820-5","article-title":"Robot-assisted hysterectomy for endometrial cancer: Is there a correlation between uterine diameters, pelvic volume, and surgical outcomes?","volume":"19","author":"Surico","year":"2025","journal-title":"J. Robot. Surg."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1093\/jnci\/djn397","article-title":"Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: Randomized clinical trial","volume":"100","author":"Basile","year":"2008","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0140-6736(08)61766-3","article-title":"Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): A randomised study","volume":"373","author":"Kitchener","year":"2009","journal-title":"Lancet"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"288","DOI":"10.6004\/jnccn.2014.0026","article-title":"Sentinel lymph node mapping for endometrial cancer: A modern approach to surgical staging","volume":"12","year":"2014","journal-title":"J. Natl. Compr. Canc. Netw."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/S1470-2045(17)30068-2","article-title":"A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): A multicentre, prospective, cohort study","volume":"18","author":"Rossi","year":"2017","journal-title":"Lancet Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1136\/ijgc-2020-002230","article-title":"ESGO\/ESTRO\/ESP guidelines for the management of patients with endometrial carcinoma","volume":"31","author":"Concin","year":"2021","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.3802\/jgo.2023.34.e23","article-title":"Role of systematic lymphadenectomy in patients with intermediate- to high-risk early-stage endometrial cancer","volume":"34","author":"Kim","year":"2023","journal-title":"J. Gynecol. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1097\/IGC.0000000000001039","article-title":"Lymphadenectomy in early-stage intermediate-\/high-risk endometrioid endometrial cancer","volume":"27","author":"Farrell","year":"2017","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_16","first-page":"1","article-title":"Association of lymph node count and overall survival in node-negative endometrial cancers","volume":"1","author":"Seagle","year":"2017","journal-title":"JCO Clin. Cancer Inform."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.3802\/jgo.2025.36.e3","article-title":"Prognostic impact of the number of resected pelvic nodes in endometrial cancer: Japanese Gynecologic Oncology Group Study JGOG2043 post hoc analysis","volume":"36","author":"Konno","year":"2025","journal-title":"J. Gynecol. Oncol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1002\/cncr.22185","article-title":"Therapeutic role of lymph node resection in endometrioid corpus cancer: A study of 12,333 patients","volume":"107","author":"Chan","year":"2006","journal-title":"Cancer"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"3668","DOI":"10.1200\/JCO.2005.04.144","article-title":"Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer","volume":"23","author":"Cragun","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ygyno.2005.11.032","article-title":"Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology","volume":"102","author":"Lutman","year":"2006","journal-title":"Gynecol. Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1002\/cncr.22727","article-title":"Lymphadenectomy in endometrioid uterine cancer staging: How many lymph nodes are enough?","volume":"109","author":"Chan","year":"2007","journal-title":"Cancer"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"457.e1","DOI":"10.1016\/j.ajog.2008.01.010","article-title":"Is there a therapeutic impact to regional lymphadenectomy in the surgical treatment of endometrial carcinoma?","volume":"198","author":"Iasonos","year":"2008","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.ygyno.2010.07.003","article-title":"Lymph nodes: Is total number or station number a better predictor of lymph node metastasis in endometrial cancer?","volume":"119","author":"Huang","year":"2010","journal-title":"Gynecol. Oncol."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/2\/399\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T09:21:56Z","timestamp":1771492916000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/2\/399"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,19]]},"references-count":23,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["medicina62020399"],"URL":"https:\/\/doi.org\/10.3390\/medicina62020399","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,19]]}}}